{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T03:37:42Z","timestamp":1779248262255,"version":"3.51.4"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:00:00Z","timestamp":1724371200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:00:00Z","timestamp":1724371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"DOI":"10.1186\/s12886-024-03637-w","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T22:15:53Z","timestamp":1724451353000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Risk factors for the time to development of retinopathy of prematurity in premature infants in Iran: a machine learning approach"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4378-3143","authenticated-orcid":false,"given":"Leili","family":"Tapak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3932-6062","authenticated-orcid":false,"given":"Leila Nezamabadi","family":"Farahani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8144-2323","authenticated-orcid":false,"given":"Naeeme Taslimi","family":"Taleghani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2058-9225","authenticated-orcid":false,"given":"Nazanin","family":"Ebrahimiadib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8123-4375","authenticated-orcid":false,"given":"Elias\u00a0Khalili","family":"Pour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4147-8871","authenticated-orcid":false,"given":"Afsar Dastjani","family":"Farahani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8721-3345","authenticated-orcid":false,"given":"Omid","family":"Hamidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,23]]},"reference":[{"issue":"3","key":"3637_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.5812\/ircmj.4513","volume":"15","author":"M Abrishami","year":"2013","unstructured":"Abrishami M, et al. Incidence and risk factors of retinopathy of prematurity in mashhad, northeast iran. Iran Red Crescent Med J. 2013;15(3):229.","journal-title":"Iran Red Crescent Med J"},{"key":"3637_CR2","first-page":"S89","volume":"53","author":"H Blencowe","year":"2016","unstructured":"Blencowe H, Moxon S, Gilbert C. Update on blindness due to retinopathy of prematurity globally and in India. Indian Pediatr. 2016;53:S89\u201392.","journal-title":"Indian Pediatr"},{"key":"3637_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.735335","volume":"10","author":"R-H Zhang","year":"2022","unstructured":"Zhang R-H, et al. Prevalence, years lived with disability, and time trends for 16 causes of blindness and vision impairment: findings highlight retinopathy of prematurity. Front Pediatr. 2022;10: 735335.","journal-title":"Front Pediatr"},{"issue":"8","key":"3637_CR4","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.18240\/ijo.2019.08.15","volume":"12","author":"M Khorshidifar","year":"2019","unstructured":"Khorshidifar M, et al. Incidence and risk factors of retinopathy of prematurity and utility of the national screening criteria in a tertiary center in Iran. Int J Ophthalmol. 2019;12(8):1330.","journal-title":"Int J Ophthalmol"},{"key":"3637_CR5","doi-asserted-by":"crossref","unstructured":"Liegl, R., A. Hellstr\u00f6m, and L.E. Smith, Retinopathy of prematurity: the need for prevention. Eye and brain, 2016: p. 91\u2013102.","DOI":"10.2147\/EB.S99038"},{"issue":"07","key":"3637_CR6","doi-asserted-by":"publisher","first-page":"914","DOI":"10.4103\/0366-6999.154294","volume":"128","author":"Y Chen","year":"2015","unstructured":"Chen Y, et al. Incidence and risk factors of retinopathy of prematurity in two neonatal intensive care units in North and South China. Chin Med J. 2015;128(07):914\u20138.","journal-title":"Chin Med J"},{"key":"3637_CR7","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s12098-011-0574-y","volume":"79","author":"V Sood","year":"2012","unstructured":"Sood V, et al. Changing spectrum of retinopathy of prematurity (ROP) and variations among siblings of multiple gestation. The Indian Journal of Pediatrics. 2012;79:905\u201310.","journal-title":"The Indian Journal of Pediatrics"},{"key":"3637_CR8","doi-asserted-by":"crossref","unstructured":"Yau, G.S., et al., Incidence and risk factors for retinopathy of prematurity in multiple gestations: a Chinese population study. Medicine, 2015. 94(18).","DOI":"10.1097\/MD.0000000000000867"},{"key":"3637_CR9","doi-asserted-by":"crossref","unstructured":"Kleinbaum, D.G. and M. Klein, Survival analysis a self-learning text. 1996: Springer.","DOI":"10.2307\/2532873"},{"key":"3637_CR10","doi-asserted-by":"crossref","unstructured":"Ishwaran, H., et al., Random survival forests. 2008.","DOI":"10.1214\/08-AOAS169"},{"issue":"2","key":"3637_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2023.100417","volume":"4","author":"W-C Lin","year":"2024","unstructured":"Lin W-C, et al. Oxygenation Fluctuations Associated with Severe Retinopathy of Prematurity: Insights from a Multimodal Deep Learning Approach. Ophthalmology Science. 2024;4(2): 100417.","journal-title":"Ophthalmology Science"},{"issue":"3","key":"3637_CR12","first-page":"141","volume":"13","author":"N Drazdien\u0117","year":"2006","unstructured":"Drazdien\u0117 N, et al. Multifactorial risk environment for retinopathy of prematurity. Acta Medica Lituanica. 2006;13(3):141\u20136.","journal-title":"Acta Medica Lituanica"},{"key":"3637_CR13","doi-asserted-by":"crossref","unstructured":"Aky\u00fcz-\u00dcnsal, A.\u0130., et al., Retinopathy of prematurity risk factors: Does human milk prevent retinopathy of prematurity? Turkish Journal of Pediatrics, 2019. 61(1).","DOI":"10.24953\/turkjped.2019.01.003"},{"issue":"2","key":"3637_CR14","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2174\/1573396318666220819151154","volume":"19","author":"H Boskabadi","year":"2023","unstructured":"Boskabadi H, et al. Potential role of bilirubin in preventing retinopathy of prematurity. Curr Pediatr Rev. 2023;19(2):197\u2013202.","journal-title":"Curr Pediatr Rev"},{"issue":"4","key":"3637_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2021.100070","volume":"1","author":"JS Chen","year":"2021","unstructured":"Chen JS, et al. Quantification of Early Neonatal Oxygen Exposure as a Risk Factor for Retinopathy of Prematurity Requiring Treatment. Ophthalmol Sci. 2021;1(4): 100070.","journal-title":"Ophthalmol Sci"},{"issue":"1","key":"3637_CR16","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/s41746-023-00941-5","volume":"6","author":"E Keles","year":"2023","unstructured":"Keles E, Bagci U. The past, current, and future of neonatal intensive care units with artificial intelligence: a systematic review. NPJ Digit Med. 2023;6(1):220.","journal-title":"NPJ Digit Med"},{"issue":"2","key":"3637_CR17","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41390-023-02504-6","volume":"94","author":"JA Poppe","year":"2023","unstructured":"Poppe JA, et al. Early prediction of severe retinopathy of prematurity requiring laser treatment using physiological data. Pediatr Res. 2023;94(2):699\u2013706.","journal-title":"Pediatr Res"},{"issue":"8","key":"3637_CR18","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1001\/archpedi.159.8.771","volume":"159","author":"DM Lang","year":"2005","unstructured":"Lang DM, Blackledge J, Arnold RW. Is Pacific race a retinopathy of prematurity risk factor? Arch Pediatr Adolesc Med. 2005;159(8):771\u20133.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"3637_CR19","doi-asserted-by":"crossref","unstructured":"Phan, M.H., P.N. Nguyen, and J.D. Reynolds, Incidence and severity of retinopathy of prematurity in Vietnam, a developing middle-income country. 2003, Slack Incorporated Thorofare, NJ. p. 208\u2013212.","DOI":"10.3928\/0191-3913-20030701-07"},{"issue":"5","key":"3637_CR20","doi-asserted-by":"publisher","first-page":"e518","DOI":"10.1542\/peds.2004-1180","volume":"115","author":"C Gilbert","year":"2005","unstructured":"Gilbert C, et al. Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs. Pediatrics. 2005;115(5):e518\u201325.","journal-title":"Pediatrics"},{"issue":"7","key":"3637_CR21","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1001\/archopht.123.7.991","volume":"123","author":"The International Classification of Retinopathy of Prematurity revisited","year":"2005","unstructured":"The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol. 2005;123(7):991\u20139.","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"3637_CR22","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ygeno.2012.04.003","volume":"99","author":"X Chen","year":"2012","unstructured":"Chen X, Ishwaran H. Random forests for genomic data analysis. Genomics. 2012;99(6):323\u20139.","journal-title":"Genomics"},{"issue":"5","key":"3637_CR23","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1097\/APO.0000000000000313","volume":"9","author":"R Azad","year":"2020","unstructured":"Azad R, et al. Retinopathy of prematurity: how to prevent the third epidemics in developing countries. The Asia-Pacific Journal of Ophthalmology. 2020;9(5):440\u20138.","journal-title":"The Asia-Pacific Journal of Ophthalmology"},{"issue":"6","key":"3637_CR24","doi-asserted-by":"publisher","first-page":"717","DOI":"10.4103\/ijo.IJO_496_19","volume":"67","author":"A Vinekar","year":"2019","unstructured":"Vinekar A, et al. The changing scenario of retinopathy of prematurity in middle and low income countries: Unique solutions for unique problems. Indian J Ophthalmol. 2019;67(6):717.","journal-title":"Indian J Ophthalmol"},{"issue":"2","key":"3637_CR25","doi-asserted-by":"publisher","first-page":"169","DOI":"10.47102\/annals-acadmedsg.V34N2p169","volume":"34","author":"V Shah","year":"2005","unstructured":"Shah V, et al. Incidence, risk factors of retinopathy of prematurity among very low birth weight infants in Singapore. Ann Acad Med Singapore. 2005;34(2):169\u201378.","journal-title":"Ann Acad Med Singapore"},{"issue":"2","key":"3637_CR26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000027482","volume":"214","author":"V Seiberth","year":"2000","unstructured":"Seiberth V, Linderkamp O. Risk factors in retinopathy of prematurity: a multivariate statistical analysis. Ophthalmologica. 2000;214(2):131\u20135.","journal-title":"Ophthalmologica"},{"issue":"2","key":"3637_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0171467","volume":"12","author":"LA Owen","year":"2017","unstructured":"Owen LA, et al. Retinopathy of prematurity: A comprehensive risk analysis for prevention and prediction of disease. PLoS ONE. 2017;12(2): e0171467.","journal-title":"PLoS ONE"},{"issue":"25","key":"3637_CR28","doi-asserted-by":"publisher","first-page":"16093","DOI":"10.1073\/pnas.252626999","volume":"99","author":"DE Bara\u00f1ano","year":"2002","unstructured":"Bara\u00f1ano DE, et al. Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci. 2002;99(25):16093\u20138.","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"3637_CR29","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.1651-2227.2010.02069.x","volume":"100","author":"JS Kao","year":"2011","unstructured":"Kao JS, et al. Possible roles of bilirubin and breast milk in protection against retinopathy of prematurity. Acta Paediatr. 2011;100(3):347\u201351.","journal-title":"Acta Paediatr"},{"key":"3637_CR30","unstructured":"Fereshtehnejad, S.M., et al., Evaluation of the possible antioxidative role of bilirubin protecting from free radical related illnesses in neonates. Acta Medica Iranica, 2012: p. 153\u2013163."},{"issue":"2","key":"3637_CR31","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s10792-022-02445-9","volume":"43","author":"SA Eroglu","year":"2023","unstructured":"Eroglu SA, et al. The role of hepatic and renal functions in the development of retinopathy of prematurity: Is proteinuria a new risk factor? Int Ophthalmol. 2023;43(2):483\u201390.","journal-title":"Int Ophthalmol"},{"issue":"1","key":"3637_CR32","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12886-019-1180-4","volume":"19","author":"MT Akkawi","year":"2019","unstructured":"Akkawi MT, et al. Incidence and risk factors of retinopathy of prematurity in three neonatal intensive care units in Palestine. BMC Ophthalmol. 2019;19(1):189.","journal-title":"BMC Ophthalmol"},{"issue":"4","key":"3637_CR33","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/0277-9536(95)00159-X","volume":"42","author":"AT Geronimus","year":"1996","unstructured":"Geronimus AT. Black\/white differences in the relationship of maternal age to birthweight: a population-based test of the weathering hypothesis. Soc Sci Med. 1996;42(4):589\u201397.","journal-title":"Soc Sci Med"},{"issue":"1","key":"3637_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0191002","volume":"13","author":"F Fuchs","year":"2018","unstructured":"Fuchs F, et al. Effect of maternal age on the risk of preterm birth: A large cohort study. PLoS ONE. 2018;13(1): e0191002.","journal-title":"PLoS ONE"},{"issue":"3","key":"3637_CR35","doi-asserted-by":"publisher","first-page":"359","DOI":"10.18231\/j.ijceo.2023.068","volume":"9","author":"P Maravi","year":"2023","unstructured":"Maravi P, et al. Influence of maternal factors on retinopathy of prematurity: A cross-sectional Study from a tertiary care centre. Indian Journal of Clinical and Experimental Ophthalmology. 2023;9(3):359\u201364.","journal-title":"Indian Journal of Clinical and Experimental Ophthalmology"},{"issue":"4","key":"3637_CR36","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1097\/01.AOG.0000140682.63746.be","volume":"104","author":"B Jacobsson","year":"2004","unstructured":"Jacobsson B, Ladfors L, Milsom I. Advanced maternal age and adverse perinatal outcome. Obstet Gynecol. 2004;104(4):727\u201333.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"3637_CR37","first-page":"129","volume":"101","author":"RB Russell","year":"2003","unstructured":"Russell RB, et al. The Changing Epidemiology of Multiple Births in the United States. Obstet Gynecol. 2003;101(1):129\u201335.","journal-title":"Obstet Gynecol"},{"key":"3637_CR38","doi-asserted-by":"crossref","unstructured":"Cleary-Goldman, J., et al., Impact of maternal age on obstetric outcome. Obstetrics & Gynecology, 2005. 105(5 Part 1): p. 983\u2013990.","DOI":"10.1097\/01.AOG.0000158118.75532.51"},{"key":"3637_CR39","doi-asserted-by":"crossref","unstructured":"Uchida, A., et al., Association of maternal age to development and progression of retinopathy of prematurity in infants of gestational age under 33 weeks. Journal of Ophthalmology, 2014. 2014.","DOI":"10.1155\/2014\/187929"},{"key":"3637_CR40","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s00417-009-1248-6","volume":"248","author":"JB Fortes Filho","year":"2010","unstructured":"Fortes Filho JB, et al. The influence of gestational age on the dynamic behavior of other risk factors associated with retinopathy of prematurity (ROP). Graefes Arch Clin Exp Ophthalmol. 2010;248:893\u2013900.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"3637_CR41","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/09286586.2022.2111687","volume":"30","author":"MM Estrada","year":"2023","unstructured":"Estrada MM, et al. Daily Oxygen Supplementation and Risk of Retinopathy of Prematurity. Ophthalmic Epidemiol. 2023;30(3):317\u201325.","journal-title":"Ophthalmic Epidemiol"},{"issue":"3","key":"3637_CR42","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.3390\/jcm12031228","volume":"12","author":"SH Rodriguez","year":"2023","unstructured":"Rodriguez SH, et al. Retinopathy of Prematurity in the 21st Century and the Complex Impact of Supplemental Oxygen. J Clin Med. 2023;12(3):1228.","journal-title":"J Clin Med"},{"key":"3637_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.earlhumdev.2019.104846","volume":"138","author":"A Hellstr\u00f6m","year":"2019","unstructured":"Hellstr\u00f6m A, H\u00e5rd A-L. Screening and novel therapies for retinopathy of prematurity\u2013A review. Early Human Dev. 2019;138: 104846.","journal-title":"Early Human Dev"},{"key":"3637_CR44","doi-asserted-by":"crossref","unstructured":"Vatne, A., et al., Early empirical antibiotics and adverse clinical outcomes in infants born very preterm: a population-based cohort. The Journal of Pediatrics, 2023. 253: p. 107\u2013114. e5.","DOI":"10.1016\/j.jpeds.2022.09.029"},{"issue":"1","key":"3637_CR45","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jpeds.2014.01.010","volume":"165","author":"C Greenwood","year":"2014","unstructured":"Greenwood C, et al. Early empiric antibiotic use in preterm infants is associated with lower bacterial diversity and higher relative abundance of Enterobacter. J Pediatr. 2014;165(1):23\u20139.","journal-title":"J Pediatr"},{"issue":"5","key":"3637_CR46","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.jpeds.2011.07.032","volume":"159","author":"JB Cantey","year":"2011","unstructured":"Cantey JB, S\u00e1nchez PJ. Prolonged antibiotic therapy for \u201cculture-negative\u201d sepsis in preterm infants: it\u2019s time to stop! J Pediatr. 2011;159(5):707\u20138.","journal-title":"J Pediatr"},{"issue":"3","key":"3637_CR47","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/jac\/dkx426","volume":"73","author":"JW Fjalstad","year":"2017","unstructured":"Fjalstad JW, et al. Antibiotic therapy in neonates and impact on gut microbiota and antibiotic resistance development: a systematic review. J Antimicrob Chemother. 2017;73(3):569\u201380.","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"3637_CR48","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1001\/jamaophthalmol.2023.2336","volume":"141","author":"A Pivodic","year":"2023","unstructured":"Pivodic A, et al. Prognostic value of parenteral nutrition duration on risk of retinopathy of prematurity: development and validation of the revised DIGIROP clinical decision support tool. JAMA ophthalmology. 2023;141(8):716\u201324.","journal-title":"JAMA ophthalmology"},{"issue":"4","key":"3637_CR49","doi-asserted-by":"publisher","first-page":"50","DOI":"10.17116\/oftalma201913504150","volume":"135","author":"M Petrachkova","year":"2019","unstructured":"Petrachkova M, et al. Modern approaches to predicting the development of active type 1 retinopathy of prematurity. Vestn oftalmol. 2019;135(4):50\u20139.","journal-title":"Vestn oftalmol"},{"issue":"2","key":"3637_CR50","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3390\/jpm13020291","volume":"13","author":"P-Y Wu","year":"2023","unstructured":"Wu P-Y, et al. Systemic Cytokines in Retinopathy of Prematurity. Journal of Personalized Medicine. 2023;13(2):291.","journal-title":"Journal of Personalized Medicine"},{"issue":"10","key":"3637_CR51","doi-asserted-by":"publisher","first-page":"4017","DOI":"10.1167\/iovs.15-18508","volume":"57","author":"F Bucher","year":"2016","unstructured":"Bucher F, et al. CNTF Attenuates Vasoproliferative Changes Through Upregulation of SOCS3 in a Mouse-Model of Oxygen-Induced Retinopathy. Invest Ophthalmol Vis Sci. 2016;57(10):4017\u201326.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3637_CR52","doi-asserted-by":"crossref","unstructured":"Soll, R. and E. \u00d6zek, Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome. Cochrane database of systematic reviews, 2009(1).","DOI":"10.1002\/14651858.CD000141.pub2"},{"key":"3637_CR53","doi-asserted-by":"crossref","unstructured":"Been, J.V., et al., Chorioamnionitis alters the response to surfactant in preterm infants. The Journal of pediatrics, 2010. 156(1): p. 10\u201315. e1.","DOI":"10.1016\/j.jpeds.2009.07.044"},{"issue":"15","key":"3637_CR54","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1056\/NEJM198904133201502","volume":"320","author":"JD Hobar","year":"1989","unstructured":"Hobar JD, et al. A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome. N Engl J Med. 1989;320(15):959\u201365.","journal-title":"N Engl J Med"},{"issue":"1","key":"3637_CR55","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41372-020-00779-9","volume":"41","author":"H Coshal","year":"2021","unstructured":"Coshal H, et al. Characteristics and outcomes of preterm neonates according to number of doses of surfactant received. J Perinatol. 2021;41(1):39\u201346.","journal-title":"J Perinatol"},{"issue":"3","key":"3637_CR56","first-page":"291","volume":"14","author":"M Zarei","year":"2019","unstructured":"Zarei M, et al. Prevalence and risk factors of retinopathy of prematurity in Iran. J Ophthalmic Vis Res. 2019;14(3):291.","journal-title":"J Ophthalmic Vis Res"},{"issue":"8","key":"3637_CR57","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1167\/iovs.18-24020","volume":"59","author":"EY-C Kang","year":"2018","unstructured":"Kang EY-C, et al. Retinopathy of prematurity trends in Taiwan: a 10-year nationwide population study. Invest Ophthalmol Vis Sci. 2018;59(8):3599\u2013607.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3637_CR58","doi-asserted-by":"crossref","unstructured":"Hamid, O., et al., Application of random survival forest for competing risks in prediction of cumulative incidence function for progression to AIDS. Epidemiology, Biostatistics, and Public Health, 2017. 14(4).","DOI":"10.2427\/12663"},{"issue":"1","key":"3637_CR59","first-page":"27","volume":"45","author":"O Hamidi","year":"2016","unstructured":"Hamidi O, et al. Identifying important risk factors for survival in kidney graft failure patients using random survival forests. Iran J Public Health. 2016;45(1):27.","journal-title":"Iran J Public Health"},{"issue":"2","key":"3637_CR60","first-page":"E298","volume":"63","author":"R Najafi-Vosough","year":"2022","unstructured":"Najafi-Vosough R, et al. Prediction the survival of patients with breast cancer using random survival forests for competing risks. J Prev Med Hyg. 2022;63(2):E298.","journal-title":"J Prev Med Hyg"},{"issue":"4","key":"3637_CR61","doi-asserted-by":"publisher","first-page":"8582","DOI":"10.1016\/j.eswa.2008.10.023","volume":"36","author":"IK Omurlu","year":"2009","unstructured":"Omurlu IK, Ture M, Tokatli F. The comparisons of random survival forests and Cox regression analysis with simulation and an application related to breast cancer. Expert Syst Appl. 2009;36(4):8582\u20138.","journal-title":"Expert Syst Appl"},{"issue":"3","key":"3637_CR62","first-page":"E482","volume":"61","author":"L Tapak","year":"2020","unstructured":"Tapak L, et al. Predictors of mortality among hemodialysis patients in Hamadan province using random survival forests. J Prev Med Hyg. 2020;61(3):E482.","journal-title":"J Prev Med Hyg"},{"issue":"1","key":"3637_CR63","first-page":"129","volume":"18","author":"D Adham","year":"2017","unstructured":"Adham D, Abbasgholizadeh N, Abazari M. Prognostic factors for survival in patients with gastric cancer using a random survival forest. Asian Pacific journal of cancer prevention: APJCP. 2017;18(1):129.","journal-title":"Asian Pacific journal of cancer prevention: APJCP"},{"issue":"10","key":"3637_CR64","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.3390\/cancers13102442","volume":"13","author":"M van Zutphen","year":"2021","unstructured":"van Zutphen M, et al. Identification of lifestyle behaviors associated with recurrence and survival in colorectal cancer patients using random survival forests. Cancers. 2021;13(10):2442.","journal-title":"Cancers"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-024-03637-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-024-03637-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-024-03637-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T22:26:30Z","timestamp":1724451990000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-024-03637-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,23]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3637"],"URL":"https:\/\/doi.org\/10.1186\/s12886-024-03637-w","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,23]]},"assertion":[{"value":"27 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The data were collected from medical records of the Farabi and Mahdieh Hospitals in Tehran. Therefore, a waiver of informed consent was awarded for this study by the ethical committee of Hamadan University of Medical Sciences (ethical code: IR.UMSHA.REC.1399.789). All methods were carried out in accordance with relevant guidelines and regulations, and the study was approved by the Ethical Committee of the Hamadan University of Medical Sciences.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"364"}}